id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-C-0543-0005,FDA,FDA-2009-C-0543,Listing of Color Additives Exempt from Certification: Reactive Blue 69; Confirmation of Effective Date,Rule,Final Rule,2011-09-27T04:00:00Z,2011,9,2011-09-27T04:00:00Z,,2012-03-24T19:33:33Z,2011-24795,0,0,0900006480f35047
FDA-2009-C-0543-0003,FDA,FDA-2009-C-0543,"Reference 1 - Memorandum from Division of Petition Review Chemistry Review Team to R. Davy,  Division of Petition Review Regulatory Group II [76FR25234 NFR of 5/14/2011]",Supporting & Related Material,BKG-Background Material,2011-05-05T04:00:00Z,2011,5,,,2011-05-05T14:12:00Z,,0,0,0900006480c3effe
FDA-2009-C-0543-0004,FDA,FDA-2009-C-0543,"Reference 2 - Memorandum from T. Scott Thurmond, Ph.D. Review Toxicologist OFAS Division of Petition Review toRaphael Davy, CSO OFAS/DPR Regulatory Team II  [76FR25234 NFR of 5/14/2011]",Supporting & Related Material,BKG-Background Material,2011-05-05T04:00:00Z,2011,5,,,2011-05-05T14:12:02Z,,0,0,0900006480c3f000
FDA-2009-C-0543-0002,FDA,FDA-2009-C-0543,Listing of Color Additives Exempt From Certification; Reactive Blue 69,Rule,NFR-Notice of Final Rule,2011-05-04T04:00:00Z,2011,5,2011-05-04T04:00:00Z,2011-06-04T03:59:59Z,2011-05-04T16:40:21Z,2011-10869,0,0,0900006480c3eb0f
FDA-2009-C-0543-0001,FDA,FDA-2009-C-0543,Sauflon Pharmaceuticals Ltd.; Filing of Color Additive Petition,Notice,NFL-Notice of Filing,2009-11-18T05:00:00Z,2009,11,2009-11-18T05:00:00Z,,2009-11-18T17:23:15Z,E9-27629,0,0,0900006480a59037